These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1790197)

  • 1. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland.
    Vlahov D; Muñoz A; Celentano DD; Cohn S; Anthony JC; Chilcoat H; Nelson KE
    Epidemiology; 1991 Nov; 2(6):444-6. PubMed ID: 1790197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field effectiveness of needle disinfection among injecting drug users.
    Vlahov D; Astemborski J; Solomon L; Nelson KE
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):760-6. PubMed ID: 8207660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle-cleaning practices among intravenous drug users who share injection equipment in Baltimore, Maryland.
    Latkin CA; Vlahov D; Anthony JC; Cohn S; Mandell W; Nelson KE
    Int J Addict; 1992 Jun; 27(6):717-25. PubMed ID: 1612823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.
    Solomon L; Astemborski J; Warren D; Muñoz A; Cohn S; Vlahov D; Nelson KE
    Am J Epidemiol; 1993 Apr; 137(8):892-8. PubMed ID: 8484380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland.
    Vlahov D; Muñoz A; Anthony JC; Cohn S; Celentano DD; Nelson KE
    Am J Epidemiol; 1990 Nov; 132(5):847-56. PubMed ID: 2239899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.
    Moss AR; Vranizan K; Gorter R; Bacchetti P; Watters J; Osmond D
    AIDS; 1994 Feb; 8(2):223-31. PubMed ID: 8043227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.
    van Ameijden EJ; van den Hoek JA; van Haastrecht HJ; Coutinho RA
    Am J Epidemiol; 1992 Jul; 136(2):236-43. PubMed ID: 1415145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleach use and HIV seroconversion among New York City injection drug users.
    Titus S; Marmor M; Des Jarlais D; Kim M; Wolfe H; Beatrice S
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):700-4. PubMed ID: 8207647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?
    Kapadia F; Vlahov D; Des Jarlais DC; Strathdee SA; Ouellet L; Kerndt P; Morse E EV; Williams I; Garfein RS;
    Epidemiology; 2002 Nov; 13(6):738-41. PubMed ID: 12410020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. My place, your place, and no place: behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland.
    Latkin C; Mandell W; Vlahov D; Oziemkowska M; Knowlton A; Celentano D
    Am J Community Psychol; 1994 Jun; 22(3):415-30. PubMed ID: 7879749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A.
    Vlahov D; Khabbaz RF; Cohn S; Galai N; Taylor E; Kaplan JE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):89-96. PubMed ID: 7712239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion in patients attending sexually transmitted disease clinics.
    Kassler WJ; Zenilman JM; Erickson B; Fox R; Peterman TA; Hook EW
    AIDS; 1994 Mar; 8(3):351-5. PubMed ID: 8031513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-related HIV risk behaviors and cocaine preference among injection drug users in Los Angeles.
    Longshore D; Anglin MD; Hsieh SC; Annon K
    J Drug Educ; 1993; 23(3):259-72. PubMed ID: 8263670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for HIV infection among drug users in Yunnan province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes.
    Xia M; Kreiss JK; Holmes KK
    AIDS; 1994 Dec; 8(12):1701-6. PubMed ID: 7888119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV risk factors among injecting drug users in five US cities.
    Battjes RJ; Pickens RW; Haverkos HW; Sloboda Z
    AIDS; 1994 May; 8(5):681-7. PubMed ID: 8060548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral characteristics of seroconverted intravenous drug users.
    Nemoto T
    Int J Addict; 1992 Dec; 27(12):1413-21. PubMed ID: 1452392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for HIV-1 seroconversion among injection drug users: a case-control study.
    Chitwood DD; Griffin DK; Comerford M; Page JB; Trapido EJ; Lai S; McCoy CB
    Am J Public Health; 1995 Nov; 85(11):1538-42. PubMed ID: 7485667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and practices among injecting-drug users of bleach use for equipment disinfection--New York City, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jun; 43(24):439, 445-6. PubMed ID: 8202077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV incidence among injection drug users in Baltimore, Maryland (1988-2004).
    Mehta SH; Galai N; Astemborski J; Celentano DD; Strathdee SA; Vlahov D; Nelson KE
    J Acquir Immune Defic Syndr; 2006 Nov; 43(3):368-72. PubMed ID: 16980912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users.
    Tun W; Celentano DD; Vlahov D; Strathdee SA
    AIDS; 2003 Sep; 17(13):1953-62. PubMed ID: 12960828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.